[Calcium antagonists: on the way to expanding the indications].
The paper discusses indications for the use of long-acting dihydropyridine calcium blockers, such as felodipine, as well as perspectives for using this class of drugs.
Fomin
V V
VV
D050197:Atherosclerosis / Q000188:drug therapy* / Q000378:metabolism; D002118:Calcium / Q000378:metabolism*; D002121:Calcium Channel Blockers / Q000008:administration & dosage / Q000627:therapeutic use*; D002908:Chronic Disease; D015736:Felodipine / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000378:metabolism; D007674:Kidney Diseases / Q000188:drug therapy* / Q000378:metabolism; D016896:Treatment Outcome
D002121:Calcium Channel Blockers; D015736:Felodipine; D002118:Calcium